Information technology
Imprecise research threatens precision medicine | STATThe right treatment for the right patient at the right time. That's the mantra of what's being called precision medicine. To date, though, imprecision medicine might be a better moniker.
Pharmaceuticals
IRS is urged to investigate Gilead for 'dodging' U.S. taxes | STATAn advocacy group is urging the U.S. Internal Revenue Service and the U.S. Treasury Department to investigate Gilead Sciences for allegedly shifting billions of dollars of income offshore to avoid paying taxes.
Pharmaceutical lobby shakeup precedes drug price battle | Roll Call
The Washington lobbying group representing big pharmaceutical manufacturers is shedding high-level officials even as it prepares for what is shaping up to be an intense battle over rising prescription drug prices.
Do the Merck HPV ads guilt-trip parents or tell hard truths? Both. | The Washington Post
Merck, which is running its first television commercials on human papillomavirus in half a dozen years, has ignited a fierce debate over whether the pharmaceutical giant is trying to “shame” parents into getting their children vaccinated for the most common sexually transmitted infection.
Driven to suicide by an 'inhuman and unnatural' pressure to sell | The New York Times
A six-month investigation by The New York Times found that in the push to win customers in India's chaotic and highly competitive drug market, some Abbott managers instructed employees to pursue sales at virtually any cost – in violation of Indian law, professional medical standards and the company's own ethics and guidelines.
Dems versus GOP on new drugs | The Wall Street Journal
In an opinion piece, Newt Gingrich writes that the Democratic Party “fails to recognize the vital importance of private funding” to accelerate medical research as opposed to the Republican Party.
Safety, quality and clinical practice
Steep rise in U.S. babies born to opioid-addicted mothers | UPI.comTriggered by a national epidemic of opioid painkiller abuse, the number of babies born with opioid withdrawal symptoms quadrupled in the U.S. between 1999 and 2013, according to the Centers for Disease Control and Prevention.
